SIRT5 and metabolic disease: Research indicates that succinyltransferases and de-succinylases promote or inhibit the progression of various cancers by regulating the succinylation levels of substrate targets (39–41).SIRT5, the only known mitochondrial desuccinylase, is associated with metabolic disorders and cancer (42, 43).